ESC 365 - Efficacy of the PCSK9 inhibitor for lipid-rich coronary plaque reduction: a near-infrared spectroscopy analysis

ESC Premium Access

Efficacy of the PCSK9 inhibitor for lipid-rich coronary plaque reduction: a near-infrared spectroscopy analysis

Session: Intravascular imaging and physiology to optimise outcomes

Topic: Intracoronary Ultrasound

Speaker: Doctor H. Ota (Gifu, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Hideaki Ota

Gifu Heart Center, Gifu (Japan)

0 follower

7 more presentations in this session

A novel parameter for stent expansion is superior to conventional parameters for predicting adverse events after drug-eluting stent implantation

Speaker: Doctor A. Katsura (Sagamihara, JP)

OCT guidance during primary PCI may increase long-term risk of device oriented events: subanalysis of ROBUST study

Speaker: Doctor M. Jakl (Brno, CZ)

Optical coherence tomography derived predictors of restenosis after non-stenting coronary intervention with drug-coated balloon

Speaker: Doctor S. Nakagama (Tokyo, JP)

Usefulness of the trans-stent fractional flow reserve gradient for predicting clinical outcomes

Speaker: Professor H. Lim (Suwon, KR)

Gender differences in long-term outcomes in patients with deferred revascularization following fractional flow reserve assessment: international collaboration registry of physiologic evaluation

Speaker: Doctor M. Hoshino (Amsterdam, NL)

Access the full session

Intravascular imaging and physiology to optimise outcomes

Speakers: Doctor H. Ota, Doctor A. Katsura, Doctor M. Jakl, Doctor S. Nakagama, Professor H. Lim...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources